SuperGen
SuperGen operates a pharmaceutical compnay dedicated to the research and discovery of oncological drug therapy.
Business Model:
Revenue: $0
Employees: 51-200
Rankings
Industries / Tags:
Detailed SuperGen Information
Geographic Data
Address:
City: Dublin
State: California
Zip:
Country: United States
Financial Info
Stage:
series unknown
Raised Last:
$3M
Raised Total:$11M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
SuperGen, Inc., a pharmaceutical company, engages in the discovery, development, and commercialization of therapies to treat patients with cancer. Products in Development MP-470—DNA Repair Suppressor: MP-470 is a multi-targeted Tyrosine Kinase Inhibitor that is specific for mutant forms of c-kit, PDGFRa, and FLT3. These protein kinase targets are involved in the growth and proliferation of cancer cells. MP-470 is also a suppressor of Rad51, a DNA repair protein which is involved in resistance to various chemotherapy agents and radiation. SuperGen, Inc. was founded in 1991.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2009 | Venture Round | $3M | 1/2008 | Venture Round | 1 | - |
New Enterprise Associates New Enterprise Associates |
11/1999 | Venture Round | 1 | $7.6M |
Tako Ventures Tako Ventures |
1/2008 | Venture Round | 1 | - |
New Enterprise Associates New Enterprise Associates |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 4/2011 | Astex |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
